Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PalinGen InovoFlo
- Development stage
- Preclinical
- Lead developer
- Amnio Technology
- Administration
- Intraarticular, Soft Tissue Injection, Topical, Ophthalmic
01
Overview
PalinGen InovoFlo is a human amniotic fluid-derived allograft developed for use in regenerative medicine and wound care. It is a sterile, decellularized liquid product that contains a complex concentration of signaling proteins, cytokines, and growth factors—including Transforming Growth Factor beta (TGF-beta), Epidermal Growth Factor (EGF), and Vascular Endothelial Growth Factor (VEGF)—alongside high molecular weight hyaluronic acid. Developed by Amnio Technology, the product is primarily utilized in orthopedic, sports medicine, and ophthalmic applications to modulate inflammatory responses and support the natural repair of soft tissue and joints. Its mechanism of action relies on the delivery of these bioactive components to the site of injury, where they facilitate cellular recruitment, proliferation, and differentiation while providing lubrication and a biological scaffold for healing.
- Brand names
- PalinGen InovoFlo
- Other names
- InovoFlo
02
Targets
TGFB (GARP–latent transforming growth factor beta 1 complex)EGFR (Epidermal growth factor receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on PalinGen InovoFlo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PalinGen InovoFlo.